Chipscreen Biosciences, Ltd.
Clinical trials sponsored by Chipscreen Biosciences, Ltd., explained in plain language.
-
New pill aims to clear severe psoriasis skin in major trial
Disease control Recruiting nowThis study is testing a new oral medication called CS32582 for adults with moderate-to-severe plaque psoriasis. About 220 participants will take either the capsule or a placebo for up to 12 weeks to see if it safely reduces skin plaques and improves quality of life. The main goal…
Phase: PHASE1, PHASE2 • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for Tough-to-Treat lymphoma: experimental drug added to standard chemo
Disease control Recruiting nowThis study is testing if adding an experimental drug called tucidinostat to standard CHOP chemotherapy works better than CHOP alone for adults newly diagnosed with a specific type of rare T-cell lymphoma. The main goal is to see if the combination helps keep the cancer from growi…
Phase: PHASE3 • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC